1.
Meneses G. Commentary about open-label randomized controlled study of ivermectin in mild to moderate COVID-19. IMC J Med Sci [Internet]. 2021 Apr. 5 [cited 2023 Feb. 8];14(2):67-8. Available from: https://www.banglajol.info/index.php/IMCJMS/article/view/52833